PPAR-gamma receptor ligands: novel therapy for pituitary adenomas. - Wikidata - awgldk - TriplyDB

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

http://www.wikidata.org/entity/Q34985044

about

The emerging role of pituitary tumor transforming gene in tumorigenesis Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.Peroxisome Proliferator-Activated Receptors in Female Reproduction and Fertility The Treatment of Cushing's Disease.Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolism Mechanisms for pituitary tumorigenesis: the plastic pituitary.Medical treatment of Cushing's disease: Overview and recent findings.PPARG regulates gonadotropin-releasing hormone signaling in LbetaT2 cells in vitro and pituitary gonadotroph function in vivo in mice.Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study Menin represses tumorigenesis via repressing cell proliferation.Thiazolidinediones on PPARγ: The Roles in Bone Remodeling.Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study.Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly Effect of troglitazone on radiation sensitivity in cervix cancer cells.The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).PPARs and Female Reproduction: Evidence from Genetically Manipulated Mice.Emerging drugs in endometriosis.Peroxisome proliferator-activated receptors and progression of colorectal cancer.A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer Biology Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells PPAR Ligands for Cancer Chemoprevention.Autocrine IL-6 mediates pituitary tumor senescence.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis.PPARγ E3 ubiquitin ligase regulates MUC1-C oncoprotein stability.Rosiglitazone and retinoic acid inhibit proliferation and induce apoptosis in the HCT-15 human colorectal cancer cell line Effect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study.PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.Peroxisome proliferator-activated receptor (PPAR)gamma is highly expressed in normal human pituitary gland.Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.Meal intake similarly reduces circulating concentrations of octanoyl and total ghrelin in humans.

P2860

Q24548764-42717749-7A1F-4938-8A97-9AB588CA53E0 Q24629410-99CF0226-3BE7-4C24-B0A6-EB48922D9BC7 Q26738962-7109E43D-707A-4E9A-B14A-C9C9D9EB50AA Q27010590-8880A46A-E81D-4EBE-B678-6E36CEECF138 Q33215831-38F0A2BC-FB69-4AB8-ADD9-28C99E604E46 Q33579464-542C67D0-39C6-4204-95D1-0C9B5C503138 Q33630319-20985DDA-7A6D-43B8-91FD-E70318B0912C Q33735039-DBC2E160-3560-4033-B0A6-9356B3263579 Q34594089-83A3C556-1987-4B40-B590-3F2297B317E0 Q34990890-BC7AF318-AF8B-4D6F-8558-053D82BD4CB2 Q35376284-072378DF-3A7B-4D08-B31A-625F5B62C3CF Q35496098-C1243C71-E5A4-4583-8A24-B6690AF087E1 Q36068458-B811E584-01EE-493B-A5CA-D00154D92EB5 Q36114026-782C3045-6AFA-4AEF-BBB4-ED4E08525D1A Q36147952-D885BB1C-64BE-4084-AA55-32A6C52933FE Q36195948-C7DC6BFA-B777-4454-AD45-9DCD6CCC1837 Q36328530-6F14CCB2-F9A9-4E6A-8D04-344DF29124AF Q36528934-1020262C-973A-49B5-BD30-17D5E8325AED Q36580603-851A5710-E615-46CB-9B54-3B4FDF16848E Q36710291-01292B42-CFA4-450D-A153-082257B11F95 Q36743890-B4856A21-52F4-477D-8636-7FF72E3D4D9C Q36748533-94E919A5-8FE2-4AC9-AA96-A4218EBB9D14 Q36795404-23664FE2-5176-4C8E-962B-CB0917D6D405 Q37037626-9F23803C-C094-4DD7-91D6-DFD61BD5BA5E Q37116064-04766E17-08F6-4FAA-A182-685ACD00A7F1 Q37122229-8AF707B6-3424-41BB-A402-4A9E4BADBDBA Q37165190-EBB15FB2-1622-458B-8108-4BD1DFB91681 Q37706240-6DAA2E5E-7389-45F3-B7F0-884938FD4366 Q38641190-B756D19D-ACAC-4E73-A1B4-D4B5E371F8AC Q38909191-8A765977-A8F9-4F8F-B04C-635430BDFC33 Q38979944-C7B27207-4A9A-4FB0-9C60-266EAADABE19 Q39051599-0A70424B-F4D4-40BF-B3AF-2B7BCE1C13BD Q39551235-E42CD73D-7316-4D9A-A563-A515D78CF06F Q39673688-3B43F1C3-CFA1-4884-AE84-F3B46771ABE2 Q40242074-FEB76E79-F5A0-4793-94D5-20CC6E1D7535 Q40326178-E3484957-EC1F-4ED7-95C4-DE4FF744B2D8 Q40328234-A42B1B5B-424C-4BFF-BBFA-FE887722E3CC Q41429257-5FCC361D-9EFA-4956-BE79-BE29500BF251 Q42250957-F4A20DF1-58E1-46CA-A702-C094FB661CEF Q42465389-70A02ED9-7D23-41A3-80BA-C936499BB6B8

P2860

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

http://www.wikidata.org/entity/Q34985044

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@ast

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@en

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@nl

type

label

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@ast

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@en

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@nl

prefLabel

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@ast

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@en

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@nl

P1433

Q34985044-99AA6F52-C50A-4388-B06B-D66AFE1895F6

P1476

Q34985044-B71C2E66-391B-4DB2-8BCE-2B0A98208A6B

P2093

Q34985044-7041ED33-C515-4C43-8E79-62F61EAF5AAB

Q34985044-8D0CB402-ED3B-4B12-9B1E-E99D64E9214C

Q34985044-E6EA31CB-FA59-45B5-8A29-0F9A08D0AD20

P2860

Q34985044-03EDB722-51CC-4116-9C46-8D6EC6BBE328

Q34985044-0A861C93-821A-4228-8546-C2BF301FCABE

Q34985044-0AEF4995-404D-4172-8E0F-D103061A3FBC

Q34985044-2489E79C-E6C7-4D33-8424-C2561E434E65

Q34985044-267BFB2F-843A-43DB-B400-E653581E2496

Q34985044-2A4E6A54-113B-435D-8E5E-199942E07B20

Q34985044-2BBE185D-0D74-4036-AB00-F7AD00041BA4

Q34985044-2C491D4F-6D70-481D-9253-0764C4F30832

Q34985044-2DA761C8-BF8F-4CEC-BB25-4F9AADF6613F

Q34985044-35E5A7E4-9A08-4BED-976B-D745D7EC6A7B

P304

Q34985044-0FB992B1-80F3-44A7-A982-B70D5523F47F

P31

Q34985044-BD8AD0B4-6043-4744-8E28-8C5F47E17D6E

P356

Q34985044-3F40123C-0251-45FE-B3A0-880B6B127320

P407

Q34985044-2E0F315B-713C-4351-BBC5-FA763317B3CC

P433

Q34985044-0152283A-7AD9-4E4E-8376-EA0B288533E9

P478

Q34985044-929DE3D1-BCF4-4697-9178-649156E98AD8

P577

Q34985044-4429F130-EE14-4511-84E9-3BC6A4B9E757

P698

Q34985044-ECD78DFF-259A-4F98-BABF-644825E4D660

P932

Q34985044-C431F995-6C77-4464-A7AE-5014D9AB55AD

P356

P1433

Journal of Clinical Investigation

P1476

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

@en

P2093

Anthony P Heaney

http://www.w3.org/2001/XMLSchema#string

Manory Fernando

http://www.w3.org/2001/XMLSchema#string

Shlomo Melmed

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

P304

1381-1388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200316575

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12727930

http://www.w3.org/2001/XMLSchema#string

P932

154441

http://www.w3.org/2001/XMLSchema#string